Geriatric and Oncological Evaluation With Technology for Holistic Healthcare Management for Older Multimorbid Patients.

Summary

The GerOnTe TWOBE study aims to evaluate the effectiveness of the GerOnTe intervention, consisting of a renewed, patient-centred, care pathway coordinated by an APN and supported by a Health Professional Consortium and IC Technology, compared to the current standard of care in the eight different Belgian and Dutch hospitals.

Conditions

• Geriatrics
• Medical Oncology
• Critical Pathways
• Digital Technology

Interventions

OTHER

Health Professional Consortium

In the intervention group, the renewed, patient-centred care pathway will be coordinated by the Advanced Practice Nurse (APN) and will be supported by digital technology. The intervention aims to increase the involvement of the patient in the treatment decision process, to provide comprehensive care through the quarterly meeting of all professionals involved in the care of the patient during a Health Professional Consortium (HPC) and to support patient empowerment by supporting self-management by using digital tools.

DEVICE

Holis Dashboard - Holis Patient App

In the intervention group, the renewed, patient-centred care pathway will be coordinated by the Advanced Practice Nurse (APN) and will be supported by digital technology. The intervention aims to increase the involvement of the patient in the treatment decision process, to provide comprehensive care through the quarterly meeting of all professionals involved in the care of the patient during a Health Professional Consortium (HPC) and to support patient empowerment by supporting self-management by using digital tools.

Sponsors & Collaborators

• University of Bordeaux

  collaborator OTHER

• Diakonessenhuis, Utrecht

  collaborator OTHER

• University of Milan

  collaborator OTHER

• University College Dublin

  collaborator OTHER

• Oslo University Hospital

  collaborator OTHER

• International Society of Geriatric Oncology

  collaborator OTHER

• Dublin City University

  collaborator OTHER

• Universitair Ziekenhuis Brussel

  collaborator OTHER

• General Hospital Groeninge

  collaborator OTHER

• AZ Sint-Jan AV

  collaborator OTHER

• Catharina Ziekenhuis Eindhoven

  collaborator OTHER

• Reinier de Graaf Groep

  collaborator OTHER

• KU Leuven

  collaborator OTHER

• Universitaire Ziekenhuizen KU Leuven

  lead OTHER

Principal Investigators

• Hans Wildiers, prof. dr. · Coordinator multidisciplinary breast centre (MBC)

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Model

CROSSOVER

Eligibility

Min Age

70 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-06-30

Primary Completion

2024-08-08

Completion

2024-08-08

Countries

• Belgium

Study Locations